×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CMPX – compass therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CMPX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/10
11:08 am
cmpx
Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
Neutral
Report
Is Compass Therapeutics, Inc. (CMPX) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]
12/10
08:14 am
cmpx
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer [Yahoo! Finance]
Medium
Report
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer [Yahoo! Finance]
12/10
08:00 am
cmpx
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
Medium
Report
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
12/2
08:00 am
cmpx
Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
Low
Report
Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
11/16
06:03 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Low
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
11/15
09:09 am
cmpx
Compass Therapeutics, Inc. (NASDAQ: CMPX) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $4.00 price target on the stock, down previously from $5.00.
High
Report
Compass Therapeutics, Inc. (NASDAQ: CMPX) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $4.00 price target on the stock, down previously from $5.00.
11/13
08:30 am
cmpx
Compass Therapeutics to Participate in Upcoming Investor Events
High
Report
Compass Therapeutics to Participate in Upcoming Investor Events
11/12
08:00 am
cmpx
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Medium
Report
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
08:00 am
CMPX
compass therapeutics, inc.
BEAT
Report
-5.3%
compass therapeutics, inc.
8/12/2024
08:00 am
CMPX
compass therapeutics, inc.
IN-LINE
Report
-5.0%
compass therapeutics, inc.
5/13/2024
08:00 am
CMPX
compass therapeutics, inc.
BEAT
Report
-0.6%
compass therapeutics, inc.
3/21/2024
09:00 am
CMPX
compass therapeutics, inc.
MISS
Report
-3.0%
compass therapeutics, inc.
Date
Time
Symbol
Headline
Impact
12/10
02:03 pm
cmpx
Form 4 Compass Therapeutics, For: Dec 09 Filed by: Shin Barry
Neutral
Report
Form 4 Compass Therapeutics, For: Dec 09 Filed by: Shin Barry
12/10
02:01 pm
cmpx
Form 3 Compass Therapeutics, For: Dec 09 Filed by: Shin Barry
Neutral
Report
Form 3 Compass Therapeutics, For: Dec 09 Filed by: Shin Barry
12/10
02:00 pm
cmpx
Form 3 Compass Therapeutics, For: Dec 09 Filed by: Lerner Neil
Neutral
Report
Form 3 Compass Therapeutics, For: Dec 09 Filed by: Lerner Neil
12/10
08:01 am
cmpx
Form 8-K Compass Therapeutics, For: Dec 09
Medium
Report
Form 8-K Compass Therapeutics, For: Dec 09
11/14
10:01 am
cmpx
Form SC 13G/A Compass Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Medium
Report
Form SC 13G/A Compass Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
11/12
09:36 am
cmpx
Form 10-Q Compass Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Compass Therapeutics, For: Sep 30
11/12
09:26 am
cmpx
Form 8-K Compass Therapeutics, For: Nov 12
Medium
Report
Form 8-K Compass Therapeutics, For: Nov 12
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: